Myrbetriq ER 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6U0E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,267
Award facts
- Contract value 100% obligated
- $15,267.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,267.42 delivery order to AmerisourceBergen Drug Corp for Myrbetriq ER 25 mg tablets (90-count supply) on December 5, 2025, with completion targeted for December 8, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical supply chain support for military and veteran healthcare systems. The delivery order will be fulfilled from the company's Conshohocken location.
This delivery order represents a routine pharmaceutical procurement from AmerisourceBergen's $999,999,999.00 Pharmaceutical Prime Vendor Global Program IDC with the DLA, valued through December 2026. Myrbetriq (mirabegron) is a brand-name medication used to treat overactive bladder conditions. AmerisourceBergen's extensive federal contract portfolio with the DLA encompasses a wide range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The competitive award reflects the company's demonstrated capability to meet federal procurement requirements for medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F6U0E?
SPE2DR26F6U0E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F6U0E worth?
The government has obligated $15,267 on SPE2DR26F6U0E.
Is contract SPE2DR26F6U0E an order under another contract?
Yes. SPE2DR26F6U0E is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U0E competed?
The extent of competition for SPE2DR26F6U0E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award